The effects of midodrine on patients with liver cirrhosis and refractory ascites: a randomized controlled trial
Background: Splanchnic vasodilation is a significant contributor to the development of ascites in cirrhotic patients. So, midodrine, an alpha-one agonist, may improve circulatory abnormality in cirrhotic patients via its vasoconstrictive action, thus lessening refractory ascites.Aim: To assess the e...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
african journal of gastroenterology and hepatology
2023-11-01
|
| Cyfres: | African Journal of Gastroenterology and Hepatology |
| Pynciau: | |
| Mynediad Ar-lein: | https://ajgh.journals.ekb.eg/article_325751_8bad6c7e00932478283d46e9659448ec.pdf |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|